Fair Value Calculator Fair Value Calculator
EN DE

Park Dental Partners, Inc (PARK) Fair Value & Analysis

Healthcare · US · Market cap $82.4M

PD Park Dental Partners, Inc logo Park Dental Partners, Inc PARK · US
Price$19.46
Fair Value$17.60
Upside-9.6%
Quality51/100
Watch Park Dental Partners, Inc for free, get notified when fair value or trend changes. Watch for free
Evidence: Medium Range $17.60 – $17.60

Fair value as of: Jul 18, 2026

From 16 valuation models · updated today

Fair value updated Jul 18, 2026, revised from $5,580 to $17.60 (−99.7%) since Jun 24, 2026. Share price +8.4% over the past month.

Price vs Fair Value (7 months)

$21.55 $10.25 Fair Value $17.60 Dec 2025 Jul 2026

7‑month range $10.25 – $21.55 · fair‑value band $17.60 – $17.60 · the $19.46 price screens above the $17.60 fair value. As of Jul 18, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Park Dental Partners, Inc (PARK) currently trades at $19.46, while our model-based Fair Value estimate is $17.60, implying the stock looks roughly 9.6% fairly valued today. We read business quality at 51/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Park Dental Partners, Inc generated revenue of $248M at a net margin of -0.9%. Revenue grew 6.2% year over year. It earns a return on equity of -21.9%. The balance sheet holds a net cash position of $25.1B. Fundamentals as of Jul 18, 2026

Our scenario range runs from $17.60 (bear case) to $17.60 (bull case); at $19.46, the current price sits above that range. The share trades about 14% below its 52-week high and 104% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -21% fair-value upside, at -10%, PARK screens cheaper than that median.

Key figures & financial health

Revenue (TTM) $248M
Revenue growth (YoY) +6.2%
Net margin -0.9%
Return on equity -21.9%
Free cash flow $10.3M FY2025
Operating margin -3.0%
More key figures
EPS (TTM) $-0.5100
EPS growth (YoY) +526%
Net cash $25.1B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.

About the company

Park Dental Partners, Inc. operates as a dental resource organization that provides administrative business support services to dentists in Minnesota, Wisconsin, and Arizona. The company offers general and specialty dental care services, such as dentist and hygiene, oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. It provides clinical team members, administrative personnel, and facilities and equipment to its affiliated general and multi-specialty dental practices. The company was founded in 1972 and is headquartered in Roseville, Minnesota.

Revenue & earnings trend

FY2023 – FY2025 · reported fiscal years

Park Dental Partners, Inc reported revenue of $244M in FY2025 versus $224M in FY2023, a compound +4.6%/yr. Reported net income was −$358K in FY2025.

Revenue +4.6%/yr
FY23 $224M
FY24 $230M
FY25 $244M
Net income
FY23 −$2.3M
FY24 −$8.7M
FY25 −$358K

Is PARK fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Park Dental Partners, Inc Fair Value". https://www.fairvalue-calculator.com/stock/PARK

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc H1CA34 R$96.00 R$25.67 -73%
Fresenius SE FSNUY $11.27 $8.25 -27%
IHH Healthcare Berhad, an investment holding company, Q0F 2.76 SGD 1.28 SGD -54%
Rede D'Or São Luiz S.A RDOR3 R$32.76 R$30.33 -7%
DaVita Inc DVA $192.17 $201.98 +5%
Tenet Healthcare Corporation THC $178.75 $300.86 +68%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,305 ₹2,546 -69%
Fresenius Medical Care AG FME €42.12 €71.28 +69%
Aier Eye Hospital Group 300015 ¥8.54 ¥6.73 -21%
Max Healthcare Institute Limited MAXHEALTH ₹1,010 ₹283.61 -72%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Park Dental Partners, Inc (PARK) undervalued?
As of Jul 18, 2026, our model estimates a fair value of $17.60 versus a price of $19.46, about −10% (fairly valued). Model-based estimate, not financial advice.
What is the fair value of PARK?
Our model-based fair value for Park Dental Partners, Inc is $17.60 (as of Jul 18, 2026), built from audited fundamentals. The current price is $19.46.
What is the quality score of PARK?
Park Dental Partners, Inc has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Park Dental Partners, Inc (PARK)?
Park Dental Partners, Inc reported trailing-twelve-month revenue of about $248M (latest available figure, as of Jul 18, 2026).
What is the net profit margin of PARK?
The net profit margin of Park Dental Partners, Inc is about -0.9%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Park Dental Partners, Inc analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.